Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Acute Deep Vein Thrombosis Clinical Trial

Official title:
Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study)

Status Completed

Clinical Trial Summary

To collect postmarketing data about Fragmin safety and efficacy in the treatment of deep vein thrombosis with or without pulmonary embolism in cancer patients.

Clinical Trial Description

Method: consecutive patient sampling. Patients were (are) included in the study in consecutive manner if they fulfilled the inclusion criteria and any of the exclusion criteria were not present. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00480636
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase	N/A
Start date	June 2007
Completion date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04297787` - Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT	N/A
Recruiting	`NCT03504007` - Registry of Patients Prescribed Anticoagulation
Completed	`NCT00911157` - The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients	Phase 3
Completed	`NCT02148029` - Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome	N/A